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Background: Bronchiectasis has a number of causes. Their prevalence is not well
documented. The aim of this study was to identify aetiology in a population of patients
referred to a specialist clinic with symptoms suggestive of bronchiectasis, to determine
the proportion of patients in whom knowing the aetiology altered management. In addition
we wished to describe in detail those patients who remained idiopathic to facilitate future
studies of this group; and establish the diagnosis in those without bronchiectasis.
Methods: A total of 240 consecutive patients referred to the Royal Brompton Hospital with
a history of recurrent chest infections, chronic cough and regular sputum production
underwent a 3 day program of investigation.
Results: A total of 165 patients had bronchiectasis on CT scan, an underlying cause was
identified in 122 (74%) and this affected management in 61 (37%). The common aetiologies
were: post-infection (52), primary ciliary dyskinesia (17), allergic bronchopulmonary
aspergillosis (13), and immune deficiency (11). Fourty-three patients had idiopathic
bronchiectasis. They had symmetrical predominant lower lobe disease with onset of
chronic chest and sinus symptoms in middle age.
Conclusion: Full investigation of problematic cases should occur in a specialist centre
because results affect management in a third of cases.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Bronchiectasis is defined as abnormal chronic dilatation of
one or more bronchi. Patients have a structural abnormality
of the bronchial wall that predisposes them to bacterial
infection likely due to impaired mucus clearance. A self-
perpetuating vicious cycle of chest infections and chronicElsevier Ltd. All rights reserved.
351 8337;
uk (R. Wilson).lung inflammation can lead to further damage of the
bronchial wall and spread of disease to normal areas of
bystander lung.1,2 Symptoms usually include recurrent lower
respiratory tract infections, chronic cough and regular
sputum production. Chest pains, symptoms of chronic
rhinosinusitis and undue breathlessness are also common.
Bronchiectasis has a number of causes, which include:
post-infective, e.g. childhood whooping cough or tubercu-
losis; an insult to the airway of some other kind, e.g.
aspiration of gastric contents and smoke inhalation; impair-
ment of the host defences leading to bacterial infections
(which may in some cases be hereditary), e.g. primary
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deficiency (CVID); exaggerated immune response, e.g.
allergic bronchopulmonary aspergillosis (ABPA) and inflam-
matory bowel disease; or rarely congenital causes, e.g.
Munier–Kuhn syndrome and pulmonary sequestration.1 In a
significant proportion of patients no cause is found.3
Identifying the cause of bronchiectasis may influence
management of the condition. This may relate to therapy,
e.g. patients with CVID are given immunoglobulin infusions,
and patients with ABPA may benefit from corticosteroids or
antifungal agents4–6; or it may relate to other aspects of
management, e.g. a diagnosis of PCD will influence decisions
about thoracic surgery or choice of middle ear and sinus
surgery,7 and a diagnosis of cystic fibrosis (CF) results in
genetic counselling.
Only one previous study has characterised the causes of
disease in a large population of adult patients with
bronchiectasis,3 and to date no study has reported on the
aetiology of patients who have symptoms suggesting
bronchiectasis but no disease on CT scan. Several other
papers have included aetiology as a part of a study with
wider aims.8–11 A significant proportion of patients remain
idiopathic after investigation, and the pattern of disease in
these patients has not been reported. Full investigation of
aetiology, which can only be carried out in a specialist
centre, would only be justifiable if the results influenced
management in a significant proportion of cases.
Aim
The aim of this study was to identify the aetiology in a
large cohort of adult patients referred with a history
suggesting a diagnosis of bronchiectasis. We were interested
in what proportion of patients with a diagnosis of bronch-
iectasis could be ascribed an aetiology and in what
proportion the aetiology influenced management. We
wished to contrast the results of patients with idiopathic
bronchiectasis who had been fully investigated to those of




A total of 240 consecutive patients were referred to the unit
by colleagues in secondary care hospitals and underwent a
protocol of investigations, with ethical committee approval,
into their chest condition during a 3-day stay in the minimal
dependency unit at the Royal Brompton Hospital, London.
The study was performed over a 5-year period (1st March
2001–1st March 2006). All patients entering the protocol
were new to the hospital and referred because of symptoms
suggestive of bronchiectasis. These included in all patient’s
regular sputum production, chronic cough and a history of
recurrent lower respiratory tract infections. Patients re-
ferred during this time for a specific test, e.g. ciliary
function or with a specific question about management, e.g.
antibiotic treatment of non-tuberculosis mycobacterial
infection did not go through this full protocol of investiga-
tion and were not included.Protocol of investigations
Patients underwent a pre-programmed protocol of investi-
gations as described below:
History: A complete medical history was taken from the
patient, including age of onset, chest symptoms, sputum
description, sinus and nasal symptoms, previous respiratory
illnesses including childhood history, respiratory risk factors,
and associated illnesses and conditions. Post-infective
bronchiectasis was diagnosed when the patient reported a
history of symptoms with onset immediately after a severe
infection, such as pneumonia or whooping cough. Where
possible relatives were also questioned on childhood ill-
nesses in order to try and obtain an accurate history.
Patients with a history of childhood pneumonia, but who
then had a prolonged period of no respiratory symptoms
were not classified as post-infective. Bronchiectasis asso-
ciated with inflammatory bowel disease was diagnosed
where patients had ulcerative colitis, crohn’s disease or
coeliac disease and also developed bronchiectasis (in some
cases post-colectomy).12 Young’s syndrome was diagnosed
when there was a history of bronchiectasis, sinusitis and
azoospermia in males and/or a history of mercury poisoning
or pinks disease in childhood.13 Yellow nail syndrome was
diagnosed when examination showed yellow discolouration
of dystrophic nails together with bronchiectasis and sinusi-
tis, whether or not patients had other features of the
syndrome.14
Blood investigations: Serum immunoglobulins (Ig), IgG,
IgA, IgM, IgE were measured. From March 2001 to June 2004
IgG subclasses were measured, but latterly specific antibody
levels to pneumococcal and tetanus antigens were assessed.
If these were low they were repeated 6 weeks after
vaccination. Blood investigations also included Aspergillus
fumigatus radioallergosorbent (RAST) test and IgG precipi-
tins; serum protein electrophoresis strip and urine electro-
phoresis; autoantibodies including rheumatoid factor; a1-
antitrypsin and phenotype if the level was low. A serum IgE
of 4150 IU/ml and aspergillus RAST of 410 IU/ml together
with sputum and/or peripheral blood eosinophilia, and
compatible radiology was required to fulfil the diagnosis of
ABPA.
Radiology: All patients had a digital chest radiograph (PA
and lateral), sinus radiograph and high-resolution computed
tomography (HRCT) scan. HRCTs were performed on either a
4 or 64-channel multidetector CT machine (Siemens volume
zoom; Siemens, Elangen, Germany) using a standard proto-
col of 1 or 1.5mm sections at 10mm intervals. Sections were
obtained with the patient in a supine position breath holding
at near total lung capacity. Images were reconstructed with
a high special resolution algorithm and viewed at appro-
priate window settings (Level 500, width 1500 Hounsfield
Units). Bronchiectasis was diagnosed by standard CT
criteria.15 Patients were classified from their CT scan prior
to any knowledge of their other results as, no bronchiecta-
sis, mild (one lobe with bronchiectasis), moderate (two or
three lobes with bronchiectasis), or severe (four or more
lobes with bronchiectasis or cystic changes in two or more
lobes). This classification was determined utilising the
radiology report by Dr. R. Wilson and cases in which there
was any doubt were discussed with a single radiologist (Prof.
David Hansell, Royal Brompton Hospital).
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function tests including forced expiratory volume (FEV1)
were performed.
Sputum investigations: The following investigations were
performed on fresh sputum samples. Microscopy (for cell
count of eosinophils), routine culture and antibiotic sensi-
tivities, smear and culture for acid fast bacilli (3 samples on
3 successive days).16,17
Ciliary function tests: Nasal mucociliary clearance was
measured by the saccharin test,18 and nasal nitric oxide
were performed on each patient as screening tests.19 If
these tests were abnormal the patient underwent nasal
brush biopsy. Samples were analysed for cilia beat frequency
and beat pattern under light microscopy,20 and cilia
ultrastructure was studied by electron microscopy.21
Investigations for cystic fibrosis: A sweat test was used as
a screening test.22 This was followed by cystic fibrosis
genotyping from a blood sample if the sweat test was
positive (Na+, Cl 490mu/l) or borderline (Na+ and Cl
70–90mu/l), or other features of the case (e.g. upper lobe
bronchiectasis or a family history) suggested the diagnosis.
Additional investigations: If CT scan showed localised
bronchiectasis or had unusual features a bronchoscopy was
performed. If aspiration was suggested from the history then
the patient underwent video fluoroscopy.
Idiopathic bronchiectasis
Patients who did not fulfil the definition of post-infective
and with normal or negative results of investigations into
the cause of bronchiectasis were classified as idiopathic.
The idiopathic group were compared to the post-infective
group with respect to: age at onset, age at referral,
symptoms since onset as chronic or intermittent (symp-
tom-free periods), childhood illnesses (specifically whooping
cough, complicated measles, pneumonia and whether or not
there was a history of wheeziness), presence of chronic
rhinosinusitis, number of bronchiectatic lobes and distribu-
tion of disease (whether bilateral, predominantly lower,Table 1 Aetiology of bronchiectasis.
Cause n (% of study population




Immune deficiency 11 (7)
Ulcerative colitis 5 (3)
Young’s syndrome 5 (3)
Pan bronchiolitis 4 (2)
Yellow nail syndrome 4 (2)
Mycobacterium infection 4 (2)
Rheumatoid arthritis 3 (2)
Aspiration 2 (1)
Cystic fibrosis 2 (1)
Total 165
ABPA ¼ allergic bronchopulmonary aspergillosis.
PCD ¼ primary ciliary dyskinesia.middle or upper lobe), smoking history and history of
surgery.
Statistical analysis
Groups were compared using an ANOVA or Mann–Whitney
test where data was ordinal, and a w2 test of independence
or Fisher exact test for nominal data. The appropriate test
was chosen according to group size and distribution. A
p-value of o0.05 was considered statistically significant.
Results
Bronchiectasis was present on CT scan and considered to be
the pathology accounting for the chest symptoms of 165
patients. The aetiologies determined by the investigations
are shown in Table 1. The average age of patients was 49 yr
range 17–87. Patients with conditions present since birth
(PCD n ¼ 17 and CF n ¼ 2) and primary immune deficiency
n ¼ 7 mean age (SD) 39 yr (14) were younger than patients
with idiopathic n ¼ 43 51 yr (14), post-infective n ¼ 52 49 yr
(16) and all other causes of bronchiectasis n ¼ 44 54 yr (16)
(po0.01). An aetiology was found in 122 of the 165 patients
with bronchiectasis (74%). The cause was thought to affect
future management of the patients in 61 cases (37%). These
were: PCD, ABPA, immune deficiency, ulcerative colitis, pan
bronchiolitis, mycobacterium infection, rheumatoid arthri-
tis, aspiration, CF. The majority of patients were female
(65%) which was true for all aetiologies except Young’s
syndrome, pan bronchiolitis, yellow nail syndrome, aspira-
tion and CF.
Allergic bronchopulmonary aspergillosis (n ¼ 13)
Total serum IgE was mean (SD) 2653.8 IU/ml (3806.4) The A.
fumigatus RAST in this group was mean 29.8 IU/ml
(SD ¼ 28.1) range 0.34–101 IU/ml. One patient had A.
fumigatus RAST within the normal range (o0.35)) Age (SD) No. males (% group)
49 (16) 17 (33)
51 (14) 15 (35)
36 (13) 5 (29)
54 (13) 6 (46)
47 (18) 1 (9)
48 (20) 2 (40)
56 (5) 3 (60)
46 (21) 3 (75)
55 (14) 2 (50)
62 (20) 0 (0)
65 (4) 1 (33)
67 (13) 1 (50)
41 (13) 2 (100)
49 (16) 58 (35)
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precipitins to A. niger and A. flavus. Five other patients in
this group had A. fumigatus positive precipitins. One patient
had IgE within the normal range, ABPA was diagnosed aged
13 years when he presented with left lower lobe pneumonia
which was found to be eosinophilic, aspergillus was cultured
from the sputum, there was peripheral blood eosinophilia and
aspergillus precipitins were positive. When referred to the
Brompton Hospital aged 58 his serology was no longer active.
Deficient immune response (n ¼ 11)
Seven patients had primary immune deficiency. Four
patients had CVID, with pan hypogammaglobulemia. Three
patients of 89 tested had specific polysaccharide antibody
deficiency to pneumococcal antigen (SPAD). These patients
had normal response to tetanus. Four patients had
a secondary immune deficiency due to Hodgkins lym-
phoma (2) multiple myeloma (1) and chronic lymphatic
leukaemia (1).
Abnormal mucociliary clearance (n ¼ 24)
Primary ciliary dyskinesia (n ¼ 17): Twelve patients had a
definite ultrastructural defect of their cilia. These were:
absence of both dynein arms (5), outer dynein arm defect
(4), inner dynein arm and radial spoke defect (2),
transposition defect (1). Five patients were classified as
probable PCD on the basis of suggestive history, abnormal
screening tests, abnormal ciliary beat frequency or pattern
but inconclusive electron microscopy due to the inadequate
size of the sample obtained by brush biopsy. All 17 patients
had a low nasal nitric oxide ofo100 ppb mean (SD) 34.5 ppb
(23.4). In patients with moving cilia the average ciliary beat
frequency was low n ¼ 10, 9.1Hz (3.6) (normal range
11–16Hz). In 7 patients the cilia were completely static
(0Hz). Ciliary beat pattern was reported as stiff (6), slow (4),
dyskinetic (3) and normal (1). More than one description was
used per sample. Five patients in this group had complete
situs inversus and one patient had dextrocardia alone.
Cystic fibrosis (n ¼ 2): Genotyping showed a Delta F508
homozygous in one case and Delta F508/711+3AG mutation
in the other.
Young’s syndrome (n ¼ 5): All five patients had bronch-
iectasis and sinusitis on CT. Three males had obstructive
azoospermia. The two females had a history of pinks disease
as babies and a subsequent diagnosis of bronchiectasis as
teenagers (15 and 17 yr).
Mycobacterium infection (n ¼ 4)
Two patients had bronchiectasis post tuberculosis. In two
cases bronchiectasis was thought to be due to primary
infection with Mycobacterium avium complex because of
the history and HRCT scan appearance.23
Inflammatory bowel disease (n ¼ 5)
These patients all had ulcerative colitis. Three patients had
ulcerative colitis diagnosed whilst young (aged 13–24)followed by colectomy (aged 23–35). Chest symptoms began
in two patients 6 months after surgery, the third began
producing regular sputum 10 years prior to colectomy when
her ulcerative colitis was poorly controlled. The other two
patients did not have surgery. One had an ICU admission
after being born prematurely, but was then well until
developing ulcerative colitis and a productive cough in her
teens. The other was diagnosed with ulcerative colitis in her
50 s, and developed diffuse bilateral bronchiectasis aged 65
with no other aetiological factor identified.
Yellow nail syndrome (n ¼ 4)
There was evidence of yellow discolouration of dystrophic
nails and bronchiectasis in all four patients.14 In all patients
onset of nail and chest symptoms was simultaneous. All had
sinusitis and two had peripheral lymphoedema. There were
no other features of the syndrome. Three showed improve-
ment of their nails as control of chest symptoms improved.
One patient had no nail improvement despite improvement
in the chest.
Rheumatoid disease (n ¼ 3)
In one patient chest symptoms developed aged 47 coinciding
with symptoms of rheumatoid arthritis. Rheumatoid factor
was 1 in 80. The second patient had a chest history dating
back to age 10 which worsened with the onset of acute
rheumatoid arthritis aged 34 requiring gold injections.
Rheumatoid factor was 1 in 160. The third patient had
Sjogren’s syndrome, and cough and sputum production
which began aged 35. This got progressively worse requiring
a first hospital admission for iv antibiotics age 54.
Rheumatoid arthritis was diagnosed age 53. Rheumatoid
factor was 1 in 640.
Aspiration of gastric contents (n ¼ 2)
One patient had severe gastro-oesophageal reflux and
Barrett’s oesophagus. The second had a dilated oesophagus.
Aspiration was strongly suspected from the history in both
cases but could not be confirmed by video fluoroscopy.
Pan bronchiolitis (n ¼ 4)
These four patients had widespread mild to moderate
airway dilatation with bilateral diffuse ‘tree-in-bud’ ap-
pearance on CT scan. They suffered from dyspnoea and a
productive cough. Two patients had a bronchoscopy showing
inflammation of the bronchial mucosa and biopsy which
showed infiltration with plasma cells, lymphocytes and
foamy cells. All four patients responded well to a prolonged
course of azithromycin.
Post-infection (n ¼ 52)
Average age of onset of symptoms in these patients was
7 years (SD ¼ 11) and the average age of referral to
Brompton was 49 yr (16). They were predominantly female
(67%). One third had a smoking history. Half suffered from
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Table 2 Comparison of characteristics of patients with idiopathic bronchiectasis and patients with bronchiectasis post
infection.
Idiopathic group Post-infection group p-value
n 43 52
Gender No. males (%) 15 (35) 17 (33) ns
Age at onset (SD) 43 (15) 7 (11) o0.01
Age at referral to Royal Brompton Hospital (SD) 51 (14) 49 (16) ns
Mean number of lobes involved (SD) 4.1 (1.7) 4.3 (1.7) ns
Bilateral bronchiectasis (%) 41 (95) 49 (94) ns
Predominantly lower lobe bronchiectasis (%) 32 (74) 24 (46) o0.01
Chronic rhinosinusitis (%) 36 (84) 26 (50) o0.01
Wheezy bronchitis in childhood (%) 11 (26) 11 (21) ns
P. aeruginosa (%) 14 (33) 17 (33) ns
Symptoms chronic since onset 36 (84) 25 (48) o0.01
Smoking history (%) 13 (30) 17 (33) ns
Lobectomy (%) 1 (2) 5 (10) ns
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bronchiectasis, the lower lobes were the worse affected in
half the patients. Wheezy bronchitis in childhood was
described by a minority of patients (21%). Fourty-seven
patients developed bronchiectasis following a childhood
infection. These infections were unspecified pneumonia
(28), whooping cough (16), and complicated measles (3).
Five patients developed bronchiectasis following an infec-
tion in adulthood. Five patients had received lung surgery
for their bronchiectasis. Table 2 shows the characteristics of
these patients compared with the idiopathic group.Idiopathic bronchiectasis (n ¼ 43)
Average age of onset of symptoms in these patients was 43
years (SD ¼ 15) and the average age of referral to Brompton
was 51 yr (14) (Table 2). They were predominantly female
(65%). Almost all suffered from chronic rhinosinusitis. One-
third (30%) had a smoking history (mean 11 pack years). This
was similar to the group in whom aetiology was diagnosed
(30%). The majority (84%) described their symptoms as
chronic since onset and only a small proportion (14%)
described an acute viral like illness at onset of their
symptoms. Wheezy bronchitis in childhood was described
by a minority of patients (26%). A quarter (n ¼ 10) did
describe childhood pneumonia, but then suffered no further
respiratory symptoms until middle age. The group as a whole
had predominantly symmetrical lower lobe bilateral bronch-
iectasis but the 10 patients who gave a history of childhood
pneumonia had more widespread disease particularly invol-
ving the middle lobes in 5 of 10 cases, whereas in only 2 of
the remaining 33 cases was the disease not predominantly
lower lobe (po0.005). The group with a past history of
childhood pneumonia was otherwise identical to the rest of
the idiopathic group.
Table 2 shows a comparison between the idiopathic and
post infective groups. The significant differences were: age
of onset; distribution of bronchiectasis; presence of chronic
rhinosinusitis and whether the onset of symptoms was
intermittent or chronic. The majority of the idiopathic
group had lower lobe bronchiectasis whereas in the post-infective group it was more variable. Nearly 84% of the
idiopathic patients described chronic rhinosinusitis com-
pared to only 50% in the post-infection group. In the
idiopathic group the majority (84%) described their symp-
toms as chronic since onset, whereas in the post-infection
group in 52% of patients symptoms started off as inter-
mittent.
Bacteriology and lung function
A total of 59% of patients had a positive sputum culture at
the time of their assessment. In PCD a much larger
proportion of patients had positive bacteriology (94%) than
in other groups. None of the five patients with ulcerative
colitis had positive sputum cultures. Chi-squared test of
independence showed no significant difference between
incidence of bacterial infection between different aetiolo-
gies (p40.05). Pseudomonas aeruginosa was present in the
sputum of 22% of the patients. There was no significant
difference between lung function or disease severity on CT
scan between different aetiologies of bronchiectasis
p40.05. FEV1 was mean (SD) 72% (24) predicted. There
was a significant relationship between CT severity score and
lung function (FEV1% predicted) compared by ANOVA, mild
n ¼ 27 mean (SD) ¼ 84.6 (24.5), moderate n ¼ 75 76.0
(24.7), severe n ¼ 63 60.2 (21.3) po0.0001. Patients with
P. aeruginosa infection had significantly reduced FEV1%
predicted n ¼ 36 mean (SD) ¼ 60.5 (20.6) compared to
infection with other bacteria n ¼ 62 mean (SD) ¼ 72.0
(25.8) or no bacteria cultured from the sputum sample
n ¼ 67 mean ¼ 76.2 (25.2) (po0.05).
Other patients
In the remaining 75 patients, 54 had no bronchiectasis on
HRCT scan. The cause of these patients symptoms were:
asthma (24), mucus hypersecretion (7), emphysema (3),
chronic sinusitis without lung disease (3), smoking-related
chronic bronchitis (2), eosinophilic bronchitis (2), recurrent
pneumonias due to aspiration (1), scarring due to previous
Mycobacterium tuberculosis infection (1), ulcerative
colitis (1), chronic lymphatic leukaemia (1), obliterative
bronchiolitis and interstitial lung disease (1), bronchial
ARTICLE IN PRESS
A. Shoemark et al.1168hyperreactivity (1), alpha-1 antitrypsin deficiency (1),
primary ciliary dyskinesia (1), hyperventilation (1), no cause
identified (4).
Twenty-one patients did have mild bronchiectasis on CT
scan but in addition had another predominant pathology
present, which explained the majority of their symptoms.
These were: asthma (9), emphysema (8), pulmonary fibrosis
(2), obliterative bronchiolitis (1) and Wegner’s granuloma-
tosis (1). These patients underwent the full protocol of
investigations and results were normal or negative. They
were excluded from the reporting of results.Discussion
Investigation of 240 patients presenting with chronic cough,
regular sputum production and recurrent chest infections,
revealed 165 to have bronchiectasis as their predominant
pathology on CT scan. A cause or association of bronchiec-
tasis was identified in 122 (74%) of these patients. This
affected management in 37%. The cases referred to our
tertiary care unit are likely to be more complex than those
seen in a less specialist hospital and are usually referred
either because of poor control of symptoms or progressive
disease. This selection process is likely to have influenced
the outcome of our study and aetiologies with more stable
disease, such as localised bronchiectasis following pneumo-
nia would likely represent a greater proportion in an
unselected population. Full investigation may not be
required in all cases of bronchiectasis, but we suggest that
the results of this study are applicable in patient’s where
their condition is causing concern and in these patients full
investigation into their disease should occur. In most
countries this would involve referral to a specialist centre
such as our own. Ascertaining the aetiology of bronchiectasis
may also allow more accurate assessment of the benefits of
treatments that may vary in their efficacy in different
groups.
A breakdown of aetiology within bronchiectasis patients
has only been studied once previously. In a study of 150
patients Pasteur et al. found that investigations similar to
those performed in the present study identified a cause in 93
cases: post-infection (44), immunological defect (12), ABPA
(11), aspiration/reflux (6), Young’s syndrome (5), CF (4),
rheumatoid arthritis (4), PCD (3), ulcerative colitis (2), pan
bronchiolitis (1) and congenital (1).3 Broadly speaking our
results are similar to those of Pasteur et al. The greater
prevalence of patients with PCD may have occurred because
our hospital is a specialist centre for the diagnosis of PCD,
but we feel that this is unlikely to be the explanation
because patients referred for ciliary function assessment
because this was the suspected diagnosis were not included
in the analysis. This suggests that the prevalence of PCD is
greater than previously reported. The finding that ABPA was
the cause of bronchiectasis in 8% in the present study is in
keeping with estimations of ABPA as a cause of bronchiec-
tasis in 10% of cases.6
Our finding of an immunodeficiency as a cause of
bronchiectasis was similar to the study of Pasteur et al.
The distribution of IgG subclasses in the serum of healthy
adults is skewed, and severe or even complete absence of a
subclass has been found in healthy controls.24,25 This haslead to a change in our investigation protocol and a
reclassification of patients previously diagnosed as having
subclass deficiency if their pneumococcal responses were
normal. Only three cases in our study failed to generate an
antibody response to polysaccharide antigen, which has
recently been suggested to account for a much larger
proportion of cases.26 This does not support the idea that
this form of immune deficiency accounts for a significant
proportion of idiopathic cases which had been missed
because total antibody levels were normal.
In both studies there are a large proportion of bronch-
iectasis cases caused by childhood infection. In the present
study infection made up 32% of the cases and 44% in the
Pasteur study. We have defined post-infective bronchiectasis
when the symptoms suggesting bronchiectasis followed
directly after a severe infection. This increases the chances
of a causal relationship and lessens the influence of patient
recall. However, it makes it likely that some of the patients
we have classified as idiopathic are in fact post-infective. It
is notable that summing idiopathic and post-infective,
respectively, in published series produces the same result:
53.29 (82%),3 25.65 (90%),8 81.16 (97%),11 36.46 (82%).10
However the total (idiopathic plus post-infective) in the
present study is less (58%) possibly because a population of
patients referred because of poor control of symptoms
contain less patients with these aetiologies. A recent study
of a paediatric population of non-CF bronchiectasis patients
shows a marked decrease of post-infective cases, compared
to a similar study in the 1960s when most of the patient’s in
our study were children.27 This has been attributed to a
decrease in the prevalence of measles, TB and pertussis in
the UK since the institution of vaccination programmes and
the ready availability of antibiotic therapy. If this trend is
true, future studies may document a fall in the proportion of
cases with childhood infection as the cause of adult
bronchiectasis. Although these cases had symptoms of
bronchiectasis from childhood, they were not referred to our
specialist centre until middle age when a deterioration in
symptom control led to referral. The cause for this deteriora-
tion was often unclear. Only three cases had bronchiectasis
caused by an infection in adulthood. We believe that these
patients may be more straight forward to manage and
therefore will not be referred to a specialist centre.
The average age of the study group was 49 years and the
group was predominantly female (65%). These findings are
similar to those of Pasteur et al. in which the group age was
52 years and 63% female. However, in a similar study of
children with bronchiectasis there was an equal sex
distribution.27 The predominance of females was across
most aetiologies in our study, and since pathogenesis is so
varied, this makes a genetic explanation unlikely. It has
been shown that females find symptoms of chronic cough
more troublesome than males and therefore are more likely
to seek medical attention, which might in part explain the
female predominance in our study.28
In this study there was no indication that disease severity
was directly related to the different aetiologies of bronch-
iectasis in adults, although there was a relationship between
the disease severity markers themselves. Correlations
between lung function, severity of disease on HRCT scan
and infection with P. aeruginosa have previously been
reported in bronchiectasis.29,30 In patients with ulcerative
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keeping with previous reports of bronchiectasis associated
with this condition.8
We have looked closely at the patients who remained
idiopathic after completing their investigations. Wheezy
bronchitis in childhood or an acute onset involving a ‘viral-
like’ illness occurred in a minority of patients. The onset of
symptoms occurred in middle age and were usually chronic
once they had begun. The group as a whole were found to
have symmetrical bilateral predominant lower lobe bronch-
iectasis, particularly the group with no respiratory history.
The patients who gave a history of childhood pneumonia but
no further respiratory problems before developing symptoms
of bronchiectasis in middle age had more variable distribution
of disease particularly involving the middle lobes, as in
patients whose respiratory problems followed directly after
childhood pneumonia. However this finding should be viewed
with caution due to the unreliability of patients’ memory.
Otherwise the group was remarkably homogenous, and this
might suggest a common abnormality. They also differed from
the post-infective group in that they had a higher incidence
of upper respiratory tract symptoms and their chest
symptoms were chronic from onset, whereas half the post-
infective group had intermittent symptoms at onset. A recent
study carried out by our group on patients with idiopathic
bronchiectasis has suggested genetic abnormality with
impaired HLA class I expression and natural killer cell
dysfunction,31 and further studies are warranted that might
elucidate dysregulation of the inflammatory response.
Where no bronchiectasis is found on HRCT scan some of the
causes of symptomology are the same as the causes of
bronchiectasis such as PCD, ulcerative colitis, chronic lympha-
tic leukaemia and alpha-1 antitrypsin deficiency. These patients
are at risk of developing bronchiectasis in the future. In most
other cases there is another aetiology to explain the symptoms.
In conclusion, following investigation, the aetiology of
bronchiectasis can be identified in approximately two-thirds of
cases. In 37% of patients knowledge of aetiology affected future
management of their condition. Patients with idiopathic
bronchiectasis have onset of chronic symptoms in middle age
and usually have bilateral predominantly lower lobe disease.
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